News
-
-
COMMUNIQUÉ DE PRESSE
OLB Group Regains Compliance with Nasdaq Minimum Bid Price Requirement
-
-
-
-
COMMUNIQUÉ DE PRESSE
EQS-Adhoc: Uniper SE: Uniper expects lower losses for the financial year 2022
-
COMMUNIQUÉ DE PRESSE
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
-
COMMUNIQUÉ DE PRESSE
Edesa Biotech Receives Regulatory Approval for Phase 2 Vitiligo Study
-
-
COMMUNIQUÉ DE PRESSE
Bausch Health to Announce Fourth-Quarter and Full-Year 2022 Results on Feb. 23